AAPL345.28-3.63 (-1.04%) ▼|ABBV296.50+5.71 (+1.96%) ▲|ABT106.24+1.67 (+1.60%) ▲|ACN252.82+5.60 (+2.27%) ▲|ADBE254.32+6.20 (+2.50%) ▲|AMAT398.75-22.92 (-5.43%) ▼|AMD512.09-54.33 (-9.59%) ▼|AMGN470.64+9.91 (+2.15%) ▲|AMT187.51+1.63 (+0.88%) ▲|AMZN236.35-7.44 (-3.05%) ▼|AVGO328.06-16.94 (-4.91%) ▼|AXP319.58-4.13 (-1.28%) ▼|BA172.97+0.32 (+0.19%) ▲|BAC50.21-0.94 (-1.83%) ▼|BKNG148.89-1.55 (-1.03%) ▼|BLK1,154.76-21.49 (-1.83%) ▼|BMY62.86+1.47 (+2.39%) ▲|BNY147.39-1.98 (-1.33%) ▼|BRK-B545.63+3.67 (+0.68%) ▲|C121.93-3.83 (-3.05%) ▼|CAT634.18-13.21 (-2.04%) ▼|CL95.49+2.33 (+2.50%) ▲|CMCSA22.96+0.69 (+3.08%) ▲|COF204.92-3.82 (-1.83%) ▼|COP152.18+2.15 (+1.43%) ▲|COST1,011.58+16.97 (+1.71%) ▲|CRM230.96+0.06 (+0.02%) ▲|CSCO104.10-4.50 (-4.14%) ▼|CVS90.60+0.27 (+0.30%) ▲|CVX235.88+4.42 (+1.91%) ▲|DE671.37+11.37 (+1.72%) ▲|DHR233.94-3.04 (-1.28%) ▼|DIS111.54+0.63 (+0.56%) ▲|DUK127.48+1.58 (+1.26%) ▲|EMR167.35-3.39 (-1.99%) ▼|FDX316.55+8.73 (+2.84%) ▲|GD376.54+5.72 (+1.54%) ▲|GE305.51-7.55 (-2.41%) ▼|GEV865.54-22.31 (-2.51%) ▼|GILD171.89+6.28 (+3.79%) ▲|GM85.91+0.19 (+0.22%) ▲|GOOG278.53-3.79 (-1.34%) ▼|GOOGL279.67-4.15 (-1.46%) ▼|GS895.67-32.07 (-3.46%) ▼|HD328.79-0.19 (-0.06%) ▼|HON219.91-2.23 (-1.00%) ▼|IBM256.38-1.90 (-0.74%) ▼|INTC66.03-26.05 (-28.29%) ▼|INTU340.69+9.50 (+2.87%) ▲|ISRG444.16-4.60 (-1.03%) ▼|JNJ277.09+1.89 (+0.69%) ▲|JPM337.20-6.38 (-1.86%) ▼|KO94.47+1.65 (+1.78%) ▲|LIN513.79+10.64 (+2.11%) ▲|LLY1,427.41+53.71 (+3.91%) ▲|LMT642.47-1.12 (-0.17%) ▼|LOW208.43+1.15 (+0.55%) ▲|LRCX242.06-12.33 (-4.85%) ▼|MA633.48-2.22 (-0.35%) ▼|MCD258.83+1.45 (+0.56%) ▲|MDLZ64.59+2.06 (+3.29%) ▲|MDT97.24+0.13 (+0.13%) ▲|META618.49-6.03 (-0.97%) ▼|MMM176.45-0.91 (-0.51%) ▼|MO77.95+1.20 (+1.56%) ▲|MRK148.90+2.57 (+1.76%) ▲|MS184.46-4.40 (-2.33%) ▼|MSFT521.48-8.67 (-1.63%) ▼|MU892.51-41.76 (-4.47%) ▼|NEE83.43+1.29 (+1.57%) ▲|NFLX62.53+0.48 (+0.77%) ▲|NKE38.89+0.47 (+1.21%) ▲|NOW107.09-2.59 (-2.36%) ▼|NVDA206.79-6.87 (-3.22%) ▼|ORCL133.51-6.05 (-4.34%) ▼|PEP136.21+2.42 (+1.81%) ▲|PFE30.32+0.37 (+1.22%) ▲|PG163.24+2.65 (+1.65%) ▲|PLTR187.24-9.18 (-4.67%) ▼|PM210.36+1.86 (+0.89%) ▲|QCOM167.72-17.69 (-9.54%) ▼|RTX200.05+0.65 (+0.33%) ▲|SBUX103.34-2.17 (-2.06%) ▼|SCHW88.66-0.82 (-0.91%) ▼|SO94.04+1.05 (+1.12%) ▲|SPG216.89+1.17 (+0.54%) ▲|T21.46+0.54 (+2.56%) ▲|TMO703.64-5.54 (-0.78%) ▼|TMUS155.31+8.02 (+5.45%) ▲|TSLA396.93-6.37 (-1.58%) ▼|TXN302.07-9.35 (-3.00%) ▼|UBER65.09-0.65 (-0.99%) ▼|UNH408.45-2.46 (-0.60%) ▼|UNP302.17+0.24 (+0.08%) ▲|UPS108.29+0.96 (+0.90%) ▲|USB59.98-0.66 (-1.09%) ▼|V413.10+2.56 (+0.62%) ▲|VZ44.83+1.17 (+2.67%) ▲|WFC83.93-0.89 (-1.04%) ▼|WMT123.13+1.88 (+1.55%) ▲|XOM187.59+4.30 (+2.35%) ▲|AAPL345.28-3.63 (-1.04%) ▼|ABBV296.50+5.71 (+1.96%) ▲|ABT106.24+1.67 (+1.60%) ▲|ACN252.82+5.60 (+2.27%) ▲|ADBE254.32+6.20 (+2.50%) ▲|AMAT398.75-22.92 (-5.43%) ▼|AMD512.09-54.33 (-9.59%) ▼|AMGN470.64+9.91 (+2.15%) ▲|AMT187.51+1.63 (+0.88%) ▲|AMZN236.35-7.44 (-3.05%) ▼|AVGO328.06-16.94 (-4.91%) ▼|AXP319.58-4.13 (-1.28%) ▼|BA172.97+0.32 (+0.19%) ▲|BAC50.21-0.94 (-1.83%) ▼|BKNG148.89-1.55 (-1.03%) ▼|BLK1,154.76-21.49 (-1.83%) ▼|BMY62.86+1.47 (+2.39%) ▲|BNY147.39-1.98 (-1.33%) ▼|BRK-B545.63+3.67 (+0.68%) ▲|C121.93-3.83 (-3.05%) ▼|CAT634.18-13.21 (-2.04%) ▼|CL95.49+2.33 (+2.50%) ▲|CMCSA22.96+0.69 (+3.08%) ▲|COF204.92-3.82 (-1.83%) ▼|COP152.18+2.15 (+1.43%) ▲|COST1,011.58+16.97 (+1.71%) ▲|CRM230.96+0.06 (+0.02%) ▲|CSCO104.10-4.50 (-4.14%) ▼|CVS90.60+0.27 (+0.30%) ▲|CVX235.88+4.42 (+1.91%) ▲|DE671.37+11.37 (+1.72%) ▲|DHR233.94-3.04 (-1.28%) ▼|DIS111.54+0.63 (+0.56%) ▲|DUK127.48+1.58 (+1.26%) ▲|EMR167.35-3.39 (-1.99%) ▼|FDX316.55+8.73 (+2.84%) ▲|GD376.54+5.72 (+1.54%) ▲|GE305.51-7.55 (-2.41%) ▼|GEV865.54-22.31 (-2.51%) ▼|GILD171.89+6.28 (+3.79%) ▲|GM85.91+0.19 (+0.22%) ▲|GOOG278.53-3.79 (-1.34%) ▼|GOOGL279.67-4.15 (-1.46%) ▼|GS895.67-32.07 (-3.46%) ▼|HD328.79-0.19 (-0.06%) ▼|HON219.91-2.23 (-1.00%) ▼|IBM256.38-1.90 (-0.74%) ▼|INTC66.03-26.05 (-28.29%) ▼|INTU340.69+9.50 (+2.87%) ▲|ISRG444.16-4.60 (-1.03%) ▼|JNJ277.09+1.89 (+0.69%) ▲|JPM337.20-6.38 (-1.86%) ▼|KO94.47+1.65 (+1.78%) ▲|LIN513.79+10.64 (+2.11%) ▲|LLY1,427.41+53.71 (+3.91%) ▲|LMT642.47-1.12 (-0.17%) ▼|LOW208.43+1.15 (+0.55%) ▲|LRCX242.06-12.33 (-4.85%) ▼|MA633.48-2.22 (-0.35%) ▼|MCD258.83+1.45 (+0.56%) ▲|MDLZ64.59+2.06 (+3.29%) ▲|MDT97.24+0.13 (+0.13%) ▲|META618.49-6.03 (-0.97%) ▼|MMM176.45-0.91 (-0.51%) ▼|MO77.95+1.20 (+1.56%) ▲|MRK148.90+2.57 (+1.76%) ▲|MS184.46-4.40 (-2.33%) ▼|MSFT521.48-8.67 (-1.63%) ▼|MU892.51-41.76 (-4.47%) ▼|NEE83.43+1.29 (+1.57%) ▲|NFLX62.53+0.48 (+0.77%) ▲|NKE38.89+0.47 (+1.21%) ▲|NOW107.09-2.59 (-2.36%) ▼|NVDA206.79-6.87 (-3.22%) ▼|ORCL133.51-6.05 (-4.34%) ▼|PEP136.21+2.42 (+1.81%) ▲|PFE30.32+0.37 (+1.22%) ▲|PG163.24+2.65 (+1.65%) ▲|PLTR187.24-9.18 (-4.67%) ▼|PM210.36+1.86 (+0.89%) ▲|QCOM167.72-17.69 (-9.54%) ▼|RTX200.05+0.65 (+0.33%) ▲|SBUX103.34-2.17 (-2.06%) ▼|SCHW88.66-0.82 (-0.91%) ▼|SO94.04+1.05 (+1.12%) ▲|SPG216.89+1.17 (+0.54%) ▲|T21.46+0.54 (+2.56%) ▲|TMO703.64-5.54 (-0.78%) ▼|TMUS155.31+8.02 (+5.45%) ▲|TSLA396.93-6.37 (-1.58%) ▼|TXN302.07-9.35 (-3.00%) ▼|UBER65.09-0.65 (-0.99%) ▼|UNH408.45-2.46 (-0.60%) ▼|UNP302.17+0.24 (+0.08%) ▲|UPS108.29+0.96 (+0.90%) ▲|USB59.98-0.66 (-1.09%) ▼|V413.10+2.56 (+0.62%) ▲|VZ44.83+1.17 (+2.67%) ▲|WFC83.93-0.89 (-1.04%) ▼|WMT123.13+1.88 (+1.55%) ▲|XOM187.59+4.30 (+2.35%) ▲|
15.1 C
New York
Friday, October 30, 2026

Tag: forms

Verizon announces private exchange offers for 10 series of notes and related tender offers open to certain investors

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the commencement of two related transactions to repurchase 10 series of its outstanding notes listed in the tables below.

Morphy’s to Host June 21 Live Auction of Elite Western Art and Antiques During 35th Annual Old West Show in Santa Fe

Original black eye mask and pair of Colt Single Action Revolvers screen-used by Clayton Moore, legendary star of TV series The Lone Ranger, have...

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte®. Pred Forte and its design are trademarks of Allergan, Inc., an AbbVie company. Launch of this product is planned for the third quarter of 2025.

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid (“mRNA”). The all-stock transaction will bring together two highly complementary companies based in Germany and will build on BioNTech’s proven track record and established position in the global mRNA industry.

Etsy Announces Pricing of $650 Million of Convertible Senior Notes Offering

BROOKLYN, N.Y., June 12, 2025 /PRNewswire/ -- Etsy, Inc. (Nasdaq: ETSY), which operates two-sided online marketplaces that connect millions of passionate and creative buyers...

AI Firm Enhances Automation Capabilities—Assessing Job Market Impact on Algorithmic Models

In the evolving landscape of artificial intelligence, the paradigm is shifting from augmentation to comprehensive automation. Initially, Silicon Valley's rhetoric centered on AI as...

Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma

Paris, France – June 12, 2025

Enterome SA
, a clinical-stage company developing first-in-class OncoMimics™ immunotherapies to treat cancer, has raised $19 million in a new private financing to advance its lead clinical program EO2463 OncoMimics™ immunotherapy to treat indolent non-Hodgkin lymphoma (iNHL). The new funds will be used to expand and finalize the ongoing Phase 1/2 SIDNEY clinical trial of EO2463 and prepare the candidate for a registrational trial.

UK leads G7 countries in addressing child sexual violence, but ODA cuts are hurting progress

An assessment of five indicators illuminate how the world’s richest nations are addressing the global crisis of childhood sexual violence, UK leads the way

Multiple Sclerosis Market to Grow Rapidly at a CAGR of 3.8% During the Forecast Period (2025-2034) | DelveInsight

The multiple sclerosis market is growing due to rising prevalence, earlier diagnosis, and wider access to care. Demand is fueled by advancements in DMTs...

AUSTRALIA-FOUNDED OTHELIA TECHNOLOGIES EXPANDS TO U.S. AND NAMES SCOTT GREENBERG EXECUTIVE CHAIRMAN

Alexandra Hooven Appointed Chief Growth Officer, Joining CEO Kate Armstrong-Smith, CTO Joe Couch and Greenberg as Company Moves to Build Story Design and Management...

1-Hour Payday Loans with No Credit Check & $100 Guaranteed – A New Feature by Wizzay

New York City, NJ, June 11, 2025 (GLOBE NEWSWIRE) --

Wizzay.com has announced improvements to its web-based lending platform, allowing consumers to obtain 1 hour payday loans through a network of partner lenders. The platform establishes borrowers in contact with direct lender partners who offer payday loans no credit check, guaranteeing same day funding for emergency cash needs. The service responds to increasing consumer demand for expedited access to short-term financial options without conventional credit checks.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsForms